1. Home
  2. GROV vs CTSO Comparison

GROV vs CTSO Comparison

Compare GROV & CTSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Grove Collaborative Holdings Inc.

GROV

Grove Collaborative Holdings Inc.

HOLD

Current Price

$1.41

Market Cap

58.4M

ML Signal

HOLD

Logo Cytosorbents Corporation

CTSO

Cytosorbents Corporation

HOLD

Current Price

$0.79

Market Cap

45.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GROV
CTSO
Founded
2016
1997
Country
United States
United States
Employees
415
N/A
Industry
Package Goods/Cosmetics
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
58.4M
45.7M
IPO Year
N/A
2008

Fundamental Metrics

Financial Performance
Metric
GROV
CTSO
Price
$1.41
$0.79
Analyst Decision
Buy
Buy
Analyst Count
2
2
Target Price
$1.60
$5.38
AVG Volume (30 Days)
59.9K
62.9K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$22,503,908.00
Revenue This Year
N/A
$7.29
Revenue Next Year
$3.63
$8.91
P/E Ratio
N/A
N/A
Revenue Growth
N/A
48.53
52 Week Low
$1.02
$0.60
52 Week High
$1.72
$1.39

Technical Indicators

Market Signals
Indicator
GROV
CTSO
Relative Strength Index (RSI) 44.07 71.89
Support Level $1.19 $0.62
Resistance Level $1.46 $0.85
Average True Range (ATR) 0.07 0.04
MACD -0.02 0.02
Stochastic Oscillator 32.09 100.00

Price Performance

Historical Comparison
GROV
CTSO

About GROV Grove Collaborative Holdings Inc.

Grove Collaborative Holdings Inc is engaged in providing consumer products. It offers Cleaning accessories, Home and Pantry, Personal care products, Pets supplements and Other products. It is a sustainability oriented consumer products generator. It use connection with consumers to create and curate authentic, disruptive brands and products. Company builds natural products that perform as well as, many consumer packaged goods (CPG) brands (both conventional and natural), while being healthier for consumers and the planet.

About CTSO Cytosorbents Corporation

CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.

Share on Social Networks: